Nutrition researchers at the University of Illinois Chicago studied 80 people with nonalcoholic fatty liver disease and found that those who followed an alternate-day fasting diet and exercised were able to improve their ...
Feb 14, 2023
0
85
Nightly use of 0.05 percent atropine eye drops compared with placebo results in a significantly lower incidence of myopia and a lower percentage of patients with fast myopic shift at two years among children aged 4 to 9 years ...
Feb 14, 2023
0
6
Viral suppression of HIV by antiretroviral medications helps slow transmission of the disease and keep individuals living with it healthy, at times making viral loads so low they are undetectable even on blood tests. Sixty-five ...
Feb 9, 2023
0
3
In a first of its kind randomized controlled trial an international team of researchers led by the Butler Columbia Aging Center at the Columbia University Mailman School of Public Health shows that caloric restriction can ...
Feb 9, 2023
0
116
Patients with glioblastoma—the deadliest type of primary brain tumor—may potentially benefit from immunotherapy medications called immune checkpoint inhibitors that stimulate an immune response against cancer cells.
Feb 2, 2023
0
30
Exercise helped Delhi college student Vinay Jani gain strength and lose weight. But in 2005, he began having seizures. Seizure control was elusive, and Jani went into a depression. He stopped exercising and gained back more ...
Jan 25, 2023
0
8
The American College of Physicians (ACP) has issued an update of its guideline with clinical recommendations for nonpharmacologic and pharmacologic treatments of adults in the acute phase of major depressive disorder (MDD). ...
Jan 23, 2023
0
39
For patients with schizophrenia spectrum disorders, implementing conventional nutritional education strategies and specific nutritional advice with a symbiotic effect improves dietary-nutritional profiles, according to a ...
Jan 23, 2023
0
2
Transfusion of convalescent COVID-19 plasma is associated with a reduction in mortality for immunocompromised patients, according to a systematic review published online Jan. 12 in JAMA Network Open.
Jan 17, 2023
0
8
Patients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent response and relapse-free survival, according to a recent clinical trial published in Blood.
Jan 13, 2023
0
21
